Target Name: KIF13B
NCBI ID: G23303
Review Report on KIF13B Target / Biomarker Content of Review Report on KIF13B Target / Biomarker
KIF13B
Other Name(s): KI13B_HUMAN | kinesin 13B | kinesin family member 13B | guanylate kinase associated kinesin | Kinesin-like protein GAKIN | KIAA0639 | GAKIN | Kinesin family member 13B | Kinesin-like protein KIF13B | OTTHUMP00000225649 | kinesin-like protein GAKIN | Kinesin 13B | Guanylate kinase associated kinesin

KIF13B: A Potential Drug Target for Tissue Repair and Regeneration

KIF13B (KI13B_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, heart, lungs, and gastrointestinal tract. It is a member of the Kallikrein-related serine proteases (KASP) family and is involved in the regulation of various cellular processes that are important for tissue repair and regeneration.

Recent studies have identified KIF13B as a potential drug target for the treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is because KIF13B has been shown to play a role in the regulation of cell proliferation, migration, and survival, which are all important factors in the development and progression of many diseases.

One of the key reasons for the potential of KIF13B as a drug target is its ability to interact with a variety of different proteins, including tyrosine kinases, which are involved in the regulation of cellular growth and survival. This interaction allows KIF13B to regulate the activity of these proteins and, in doing so, control the growth and proliferation of cells.

In addition to its role in cell signaling, KIF13B has also been shown to play a role in the regulation of cellular immune responses. This is important because many diseases, including cancer, are caused by the activation and proliferation of immune cells that are able to recognize and respond to abnormal cells in the body.

KIF13B has also been shown to be involved in the regulation of cellular adhesion, which is the process by which cells stick together to form tissues and organs. This is important because the regulation of cell adhesion is critical for the development and maintenance of tissues and organs, and is also involved in many diseases, including cancer.

Another potential mechanism by which KIF13B may be involved in the regulation of cellular processes is its role in the regulation of the cytoskeleton. The cytoskeleton is the structure that gives cells shape and stability, and is involved in many cellular processes, including cell division and movement.

In conclusion, KIF13B is a protein that has been shown to play a role in the regulation of various cellular processes that are important for tissue repair and regeneration. Its potential as a drug target is due to its ability to interact with a variety of different proteins, including tyrosine kinases, and its role in the regulation of cell signaling, immune responses, cellular adhesion, and cytoskeleton. Further research is needed to fully understand the role of KIF13B in these processes and to develop effective treatments for diseases that are caused by its dysfunction.

Protein Name: Kinesin Family Member 13B

Functions: Involved in reorganization of the cortical cytoskeleton. Regulates axon formation by promoting the formation of extra axons. May be functionally important for the intracellular trafficking of MAGUKs and associated protein complexes

The "KIF13B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KIF13B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

KIF14 | KIF15 | KIF16B | KIF17 | KIF18A | KIF18B | KIF19 | KIF1A | KIF1B | KIF1C | KIF20A | KIF20B | KIF21A | KIF21B | KIF22 | KIF23 | KIF23-AS1 | KIF24 | KIF25 | KIF25-AS1 | KIF26A | KIF26B | KIF27 | KIF28P | KIF2A | KIF2B | KIF2C | KIF3A | KIF3B | KIF3C | KIF4A | KIF4B | KIF5A | KIF5B | KIF5C | KIF6 | KIF7 | KIF9 | KIF9-AS1 | KIFAP3 | KIFBP | KIFC1 | KIFC2 | KIFC3 | Killer Cell Immunoglobulin-Like Receptor (KIR) | Killer cell immunoglobulin-like receptor 2DS1, transcript variant X1 | KIN | Kinesin-like protein KIF16B (isoform 1) | KIR2DL1 | KIR2DL2 | KIR2DL3 | KIR2DL4 | KIR2DL5A | KIR2DL5B | KIR2DP1 | KIR2DS1 | KIR2DS2 | KIR2DS3 | KIR2DS4 | KIR2DS5 | KIR3DL1 | KIR3DL2 | KIR3DL3 | KIR3DP1 | KIR3DS1 | KIR3DX1 | KIRREL1 | KIRREL1-IT1 | KIRREL2 | KIRREL3 | KIRREL3-AS2 | KIRREL3-AS3 | KISS1 | KISS1R | KIT | KITLG | KIZ | KIZ-AS1 | KL | KLB | KLC1 | KLC2 | KLC3 | KLC4 | KLF1 | KLF10 | KLF11 | KLF12 | KLF13 | KLF14 | KLF15 | KLF16 | KLF17 | KLF17P1 | KLF2 | KLF3 | KLF3-AS1 | KLF4 | KLF5 | KLF6